Entrar

Carter M. Suryadevara

Duke Brain Tumor Immunotherapy Program,
Department of Neurosurgery,
Department of Pathology,
Duke Brain Tumor Immunotherapy Program, Department of Neurosurgery

Duke University

BIOGRAPHY

Carter M. Suryadevara has not added Biography.

If you are Carter M. Suryadevara and would like to personalize this page please email our Author Liaison for assistance.

PUBLICATIONS

Intracerebral delivery of a third generation EGFRvIII-specific chimeric antigen receptor is efficacious against human glioma.

Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia Jan, 2014 | Pubmed ID: 24054399

EGFRvIII mCAR-modified T-cell therapy cures mice with established intracerebral glioma and generates host immunity against tumor-antigen loss.

Clinical cancer research : an official journal of the American Association for Cancer Research Feb, 2014 | Pubmed ID: 24352643

EGFRvIII-specific chimeric antigen receptor T cells migrate to and kill tumor deposits infiltrating the brain parenchyma in an invasive xenograft model of glioblastoma.

PloS one , 2014 | Pubmed ID: 24722266

Epidermal growth factor receptor and variant III targeted immunotherapy.

Neuro-oncology Oct, 2014 | Pubmed ID: 25342601

Leveraging chemotherapy-induced lymphopenia to potentiate cancer immunotherapy.

Oncoimmunology , 2014 | Pubmed ID: 25610727

Chimeric antigen receptor engineered T cells can eliminate brain tumors and initiate long-term protection against recurrence.

Oncoimmunology , 2014 | Pubmed ID: 25610729

INSTITUTIONS

Duke University

JOVE ARTICLES

Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care

Katherine Riccione^1,2,

Carter M. Suryadevara^1,3,

David Snyder¹,

Xiuyu Cui¹,

John H. Sampson^1,2,3,

Luis Sanchez-Perez¹

¹Duke Brain Tumor Immunotherapy Program, Department of Neurosurgery, Duke University,

²Department of Biomedical Engineering, Duke University,

³Department of Pathology, Duke University

Immunology and Infection

Privacidade

Termos de uso

Políticas

Entre em contato

recomende à biblioteca

Newsletter

Pesquisa

JoVE Journal
Coleções de métodos
JoVE Encyclopedia of Experiments
Arquivo

Educação

JoVE Core
JoVE Business
JoVE Science Education
JoVE Lab Manual
Centro de Recursos para Docentes
Faculty Site

Autores

Visão Geral
Processo de Publicação
Conselho Editorial
Escopo e políticas
Revisão por pares
Perguntas Frequentes
Enviar

Bibliotecários

Visão Geral
Depoimentos
Assinaturas
Acesso
Recursos
Conselho Consultivo de Bibliotecas
Perguntas Frequentes

SOBRE A JoVE

Visão Geral
Liderança
Blog
JoVE Help Center

Carter M. Suryadevara

.css-o250i3{font-size:18px;font-family:Open Sans,sans-serif;line-height:21.6px;}Duke Brain Tumor Immunotherapy Program,Department of Neurosurgery,Department of Pathology,Duke Brain Tumor Immunotherapy Program, Department of Neurosurgery

Duke University

Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care

Duke Brain Tumor Immunotherapy Program,
Department of Neurosurgery,
Department of Pathology,
Duke Brain Tumor Immunotherapy Program, Department of Neurosurgery